FFAR2 and obesity due to melanocortin 4 receptor deficiency: However, growing understanding using evolved computational in-silico analyses and their significant role in several human diseases such as obesity, diabetes, IBD, and aging, FFAR2/3 are emerging as potential therapeutic targets [117,118].